Baijiao An

Shandong Medical and Pharmaceutical University

H指数:15

被引数:679

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

1D228 Attenuates Sorafenib Resistance in Renal Cell Carcinoma Models by Dual Targeting c-Met and AXL

1D228通过双重靶向c-Met和AXL来减弱肾细胞癌模型中的索拉非尼耐药性

Cells

IF5.2

2026-08-130

Synergistic inhibition of tumor growth by MET and COX-2 targeting in gastric and colorectal cancers

通过靶向MET和COX-2协同抑制胃癌和结直肠癌肿瘤生长

Bioorganic Chemistry

IF4.7

2026-05-230

PRE

HOGA1 Suppresses Renal Cell Carcinoma Growth via Inhibiting the Wnt/β-Catenin Signalling Pathway

HOGA1通过抑制Wnt/β-Catenin信号通路抑制肾细胞癌生长

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

IF4.2

2025-03-180

OAAI

Synthesis of novel deuterated EGFR/ALK dual-target inhibitors and their activity against non-small cell lung cancer

新型氘代EGFR/ALK双靶点抑制剂的合成及其对非小细胞肺癌的抑制作用

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2025-02-010

PRE

Glucagon Enhances Chemotherapy Efficacy By Inhibition of Tumor Vessels in Colorectal Cancer

胰高血糖素通过抑制肿瘤血管增强结直肠癌化疗疗效

ADVANCED SCIENCE

IF14.1

2023-12-100

A novel c-Met/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation

CELL DEATH & DISEASE

IF9.6

2023-11-098

OAAI

Novel Dual-Target Kinase Inhibitors of EGFR and ALK Were Designed, Synthesized, and Induced Cell Apoptosis in Non-Small Cell Lung Cancer

设计、合成新型EGFR和ALK双靶点激酶抑制剂，并诱导非小细胞肺癌细胞凋亡

MOLECULES

IF4.6

2023-02-2110

OAAI

A Multifunctional Vanadium-Iron-Oxide Nanoparticle Eradicates Hepatocellular Carcinoma via Targeting Tumor and Endothelial Cells

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2022-06-1318

PRE

Design, synthesis and biological evaluation of novel 2,4-diaryl pyrimidine derivatives as selective EGFRL858R/T790M inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2021-02-0122

PREAI

The discovery of a potent and selective third-generation EGFR kinase inhibitor as a therapy for EGFR L858R/T790M double mutant non-small cell lung cancer

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-12-0120

PREAI

Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through inhibition of tubulin polymerization in vitro and in vivo

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-11-0126

PREAI

Synthesis, Evaluation, and Mechanism Study of New Tepotinib Derivatives as Antiproliferative Agents

MOLECULES

IF4.6

2019-03-255

OAAI

Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-02-0139

PREAI

Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer's disease

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2018-11-0123

PREAI

Synthesis and Biological Evaluation of Selenium-Containing 4-Anilinoquinazoline Derivatives as Novel Antimitotic Agents

新型抗有丝分裂剂含硒4-苯胺基喹唑啉衍生物的合成及生物学评价

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2018-03-0642

PREAI

Design, Synthesis, and Biological Evaluation of Novel Selenium-Containing Isocombretastatins and Phenstatins as Antitumor Agents

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2017-08-23135

PREAI

The synthesis and evaluation of new butadiene derivatives as tubulin polymerization inhibitors

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2017-06-0113

PREAI

Design, synthesis, and biological evaluation of cyclic-indole derivatives as anti-tumor agents via the inhibition of tubulin polymerization

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2017-01-0134

PREAI

Baijiao An

个人简介

教育背景

工作经历

荣誉奖项

研究方向